Tatyana Abyzov is a highly-accomplished leader in the bio-pharmaceutical industry with extensive experience in drug development, evaluation of products, technologies, and alliance opportunities. She has a diverse skill set that covers multiple modalities, including small molecules, antibodies, gene therapy, and devices. Tatyana has proven ability in strategic alliances, partnership governance, due diligence, financial modeling, and budgeting. She is skilled in leading global teams, operational restructuring, business integration, and risk management. Her strong analytical and problem-solving skills, coupled with her business acumen, make her a valuable asset to any organization. Tatyana is a graduate of Massachusetts Institute of Technology, Harvard Law School, and The Wharton School. She holds a Master's degree in Microbiology and Immunology from the University of Latvia. She has held various leadership roles in organizations such as BeiGene, Suono Bio, Shire/Takeda, Sanofi, and Genzyme. Tatyana is also a mentor and active member of the entrepreneurial community.